<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 18 Jun 2026 05:51:58 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech raises $165M via share offering and private placement</title>
   <link>http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</link>
   <description>

&lt;p&gt;Alvotech (NASDAQ: ALVO) closed an underwritten public offering on June 17, 2026, selling 26,066,667 ordinary shares at $3.75 per share, generating approximately $98 million in gross proceeds before underwriting discounts, commissions, and offering expenses.&lt;/p&gt;

&lt;p&gt;The share count includes 3,400,000 ordinary shares issued following the full exercise by underwriters of their option to purchase additional shares. All shares in the offering were sold by Alvotech.&lt;/p&gt;

&lt;p&gt;Concurrent with the offering, Alvotech entered into subscription agreements with certain European Economic Area investors for the private placement of 17,826,666 ordinary shares at the same $3.75 per share price. The private placement is expected to generate approximately</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Equity+Offerings/Alvotech+raises+%24165M+via+share+offering+and+private+placement/26662115.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:58 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
  <item>
   <title>Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;REYKJAVIK, Iceland, June  18, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Alvotech+Announces+Closing+of+Public+Offering+and+Full+Exercise+by+Underwriters+of+Option+to+Purchase+Additional+Shares%2C+Raising+an+Aggregate+of+%24165+Million+with+Concurrent+Private+Placement/26662114.html</guid>
   <pubDate>Thu, 18 Jun 2026 05:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.15776824</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202048</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50214655</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO-SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ALVO.SDB.S</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10869727</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.32241120</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.51342512</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.73793734</category>
   	  </item>
 </channel>
</rss>
